Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


04.06.2018

6 Am Heart J
1 Am J Cardiol
2 Angiology
3 Ann Intern Med
1 Arterioscler Thromb Vasc Biol
3 Atherosclerosis
3 BMJ
2 Can J Cardiol
1 Cardiovasc Res
1 Circ Cardiovasc Interv
3 Circ Cardiovasc Qual Outcomes
1 Circ Heart Fail
4 Circ Res
7 Circulation
2 Clin Cardiol
1 Clin Chem
1 Dtsch Med Wochenschr
6 Eur Heart J
2 Int J Cardiol
11 J Am Coll Cardiol
2 J Clin Endocrinol Metab
1 J Clin Invest
1 J Mol Cell Cardiol
2 J Thorac Cardiovasc Surg
1 JAMA
1 N Engl J Med
1 PLoS One
3 Prog Cardiovasc Dis
1 Thromb Haemost


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. FORD TJ, Corcoran D, Oldroyd KG, McEntegart M, et al
    Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial.
    Am Heart J. 2018;201:86-94.
    PubMed     Text format     Abstract available

  2. MUHLESTEIN JB, May HT, Galenko O, Knowlton KU, et al
    GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    Am Heart J. 2018;202:27-32.
    PubMed     Text format     Abstract available

  3. JAKOBSEN L, Christiansen EH, Maeng M, Kristensen SD, et al
    Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian
    Am Heart J. 2018;202:49-53.
    PubMed     Text format     Abstract available

  4. O'NEILL WW, Grines C, Schreiber T, Moses J, et al
    Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.
    Am Heart J. 2018;202:33-38.
    PubMed     Text format     Abstract available

  5. BOHULA EA, Scirica BM, Fanola C, Inzucchi SE, et al
    Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
    Am Heart J. 2018;202:39-48.
    PubMed     Text format     Abstract available

  6. RAVAL AN, Cook TD, Duckers HJ, Johnston PV, et al
    The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study d
    Am Heart J. 2018;201:141-148.
    PubMed     Text format     Abstract available


    Am J Cardiol

  7. OTO A
    14th International Congress of Update in Cardiology and Cardiovascular Surgery, April 5 to 8: Presidential Invitation.
    Am J Cardiol. 2018;121.
    PubMed     Text format    


    Angiology

  8. EYUBOGLU M, Ozkurt Y
    Accurate Patient Selection for Percutaneous Coronary Intervention for Coronary Chronic Total Occlusions.
    Angiology. 2018 Jan 1:3319718778178. doi: 10.1177/0003319718778178.
    PubMed     Text format    

  9. LIU F, Ma Y, Ge H, Zhao Y, et al
    Long-Term Outcomes of Acute Myocardial Infarction in Patients With Hypertrophic Cardiomyopathy.
    Angiology. 2018 Jan 1:3319718778418. doi: 10.1177/0003319718778418.
    PubMed     Text format     Abstract available


    Ann Intern Med

  10. GOEL A
    Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
    Ann Intern Med. 2018;168:JC56.
    PubMed     Text format    

  11. EBERT BL, Libby P
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.
    Ann Intern Med. 2018 May 29. pii: 2683000. doi: 10.7326/M18-0737.
    PubMed     Text format    

  12. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, et al
    Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
    Ann Intern Med. 2018 May 22. pii: 2681795. doi: 10.7326/M17-1540.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  13. JONES PD, Kaiser MA, Ghaderi Najafabadi M, Koplev S, et al
    JCAD Gene at the 10p11 Coronary Artery Disease Locus Regulates Hippo Signaling in Endothelial Cells.
    Arterioscler Thromb Vasc Biol. 2018 May 24. pii: ATVBAHA.118.310976.
    PubMed     Text format     Abstract available


    Atherosclerosis

  14. SHEN ZX, Yang QZ, Li C, Du LJ, et al
    Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
    Atherosclerosis. 2018;274:199-205.
    PubMed     Text format     Abstract available

  15. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
    Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
    Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
    PubMed     Text format     Abstract available

  16. MACHADO GP, Araujo GN, Carpes CK, Lech M, et al
    Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2018;274:212-217.
    PubMed     Text format     Abstract available


    BMJ

  17. RICCI C, Wood A, Muller D, Gunter MJ, et al
    Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study.
    BMJ. 2018;361:k934.
    PubMed     Text format     Abstract available

  18. INGRAM JR
    Atopic eczema and cardiovascular disease.
    BMJ. 2018;361:k2064.
    PubMed     Text format    


  19. Dyslipidaemia and cardiovascular risk.
    BMJ. 2018;361:k2290.
    PubMed     Text format    


    Can J Cardiol

  20. COUTURE EL, Huynh T
    Drip-and-Ship vs Watchful Waiting: What Should Be the Optimal Approach After Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation?
    Can J Cardiol. 2018;34:700-702.
    PubMed     Text format    

  21. ARBEL Y, Ko DT, Yan AT, Cantor WJ, et al
    Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Can J Cardiol. 2018;34:736-743.
    PubMed     Text format     Abstract available


    Cardiovasc Res

  22. LORCHNER H, Hou Y, Adrian-Segarra JM, Kulhei J, et al
    Reg proteins direct accumulation of functionally distinct macrophage subsets after myocardial infarction.
    Cardiovasc Res. 2018 May 30. pii: 5025270. doi: 10.1093.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  23. FOURNIER S, Toth GG, De Bruyne B, Johnson NP, et al
    Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.
    Circ Cardiovasc Interv. 2018;11:e006368.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Qual Outcomes

  24. SPATZ ES, Wang Y, Beckman AL, Wu X, et al
    Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004190.
    PubMed     Text format     Abstract available

  25. UDELL JA, Desai NR, Li S, Thomas L, et al
    Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004054.
    PubMed     Text format     Abstract available

  26. ALYESH DM, Seth M, Miller DC, Dupree JM, et al
    Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004328.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  27. VIRTANEN HEK, Voutilainen S, Koskinen TT, Mursu J, et al
    Intake of Different Dietary Proteins and Risk of Heart Failure in Men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
    Circ Heart Fail. 2018;11:e004531.
    PubMed     Text format     Abstract available


    Circ Res

  28. DEMER LL, Hsu JJ, Tintut Y
    Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.
    Circ Res. 2018;122:1576-1585.
    PubMed     Text format     Abstract available

  29. PREMER C, Schulman IH
    Predictive Value of Circulating Progenitor Cells in Acute Coronary Syndrome: Implications for Treatment.
    Circ Res. 2018;122:1491-1493.
    PubMed     Text format    

  30. LAWLER PR
    Glycomics and Cardiovascular Disease: Advancing Down the Path Towards Precision.
    Circ Res. 2018;122:1488-1490.
    PubMed     Text format    

  31. ROSA-GARRIDO M, Chapski DJ, Vondriska TM
    Epigenomes in Cardiovascular Disease.
    Circ Res. 2018;122:1586-1607.
    PubMed     Text format     Abstract available


    Circulation

  32. VOLGMAN AS, Palaniappan LS, Aggarwal NT, Gupta M, et al
    Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018 May 24. pii: CIR.0000000000000580.
    PubMed     Text format     Abstract available

  33. RIJNBERG FM, Hazekamp MG, Wentzel JJ, de Koning PJH, et al
    Energetics of Blood Flow in Cardiovascular Disease: Concept and Clinical Implications of Adverse Energetics in Patients With a Fontan Circulation.
    Circulation. 2018;137:2393-2407.
    PubMed     Text format     Abstract available

  34. LOWE AL, Collet TH, Rodondi N
    Letter by Lowe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses
    Circulation. 2018;137:2415-2416.
    PubMed     Text format    

  35. KOH KK
    Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From th
    Circulation. 2018;137:2417-2418.
    PubMed     Text format    

  36. VALLEJO-VAZ AJ, Packard CJ, Ray KK
    Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL
    Circulation. 2018;137:2419-2420.
    PubMed     Text format    

  37. DEVEREAUX PJ
    Suboptimal Outcome of Myocardial Infarction After Noncardiac Surgery: Physicians Can and Should Do More.
    Circulation. 2018;137:2340-2343.
    PubMed     Text format    


  38. Correction to: Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.
    Circulation. 2018;137:e820.
    PubMed     Text format    


    Clin Cardiol

  39. YILDIZ SS, Keskin K, Avsar M, Cetinkal G, et al
    Electrocardiographic diagnosis of atrial infarction in patients with acute inferior ST-segment elevation myocardial infarction.
    Clin Cardiol. 2018 May 26. doi: 10.1002/clc.22987.
    PubMed     Text format     Abstract available

  40. LEE HM, Zhao Y, Liu MA, Yanez D, et al
    Impact of Lung Function Measures on Cardiovascular Disease Events in Older Adults with Metabolic Syndrome and Diabetes.
    Clin Cardiol. 2018 May 24. doi: 10.1002/clc.22985.
    PubMed     Text format     Abstract available


    Clin Chem

  41. KIMENAI DM, Janssen EBNJ, Eggers KM, Lindahl B, et al
    Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review.
    Clin Chem. 2018 May 29. pii: clinchem.2018.286781.
    PubMed     Text format     Abstract available


    Dtsch Med Wochenschr

  42. JUNG C, Elsasser A
    [Update ESC Guideline 2017 - Acute Myocardial Infarction (STEMI)].
    Dtsch Med Wochenschr. 2018;143:797-801.
    PubMed     Text format     Abstract available


    Eur Heart J

  43. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    PubMed     Text format    

  44. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed     Text format    

  45. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Text format     Abstract available

  46. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available

  47. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  48. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    Int J Cardiol

  49. WEI AH, Gu ZC, Zhang C, Ding YF, et al
    Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)30457.
    PubMed     Text format     Abstract available

  50. ORREM HL, Shetelig C, Ueland T, Limalanathan S, et al
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2018 May 28. pii: S0167-5273(18)31066.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  51. CHERNEY DZI, Lytvyn Y, McCullough PA
    Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab.
    J Am Coll Cardiol. 2018;71:2415-2418.
    PubMed     Text format    

  52. DUBROFF RJ
    Cardiovascular Risk Models and Statin Therapy.
    J Am Coll Cardiol. 2018;71:2490-2491.
    PubMed     Text format    

  53. RIDKER PM, MacFadyen JG, Glynn RJ, Koenig W, et al
    Inhibition of Interleukin-1beta by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2018;71:2405-2414.
    PubMed     Text format     Abstract available

  54. SINGH A, DiCarli MF, Nasir K, Bhatt DL, et al
    Reply: Cardiovascular Risk Models and Statin Therapy.
    J Am Coll Cardiol. 2018;71:2491-2492.
    PubMed     Text format    

  55. CAVENDER MA, Norhammar A, Birkeland KI, Jorgensen ME, et al
    SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.
    J Am Coll Cardiol. 2018;71:2497-2506.
    PubMed     Text format     Abstract available

  56. CHANG HJ, Lin FY, Lee SE, Andreini D, et al
    Coronary Atherosclerotic Precursors of Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:2511-2522.
    PubMed     Text format     Abstract available

  57. ZHAO D, Guallar E, Ouyang P, Subramanya V, et al
    Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
    J Am Coll Cardiol. 2018;71:2555-2566.
    PubMed     Text format     Abstract available

  58. MILLER VM, Mankad R
    Sex Steroids and Incident Cardiovascular Disease in Post-Menopausal Women: New Perspective on an Old Controversy.
    J Am Coll Cardiol. 2018;71:2567-2569.
    PubMed     Text format    

  59. BAGGETT TP, Liauw SS, Hwang SW
    Cardiovascular Disease and Homelessness.
    J Am Coll Cardiol. 2018;71:2585-2597.
    PubMed     Text format     Abstract available

  60. GOODING HC, Ning H, Gillman MW, Allen N, et al
    Predicting Cardiovascular Health in Coronary Artery Risk Development in Young Adults.
    J Am Coll Cardiol. 2018;71:2601-2602.
    PubMed     Text format    

  61. BLAHA MJ, Nasir K, Budoff MJ, Dardari ZA, et al
    Impact of C-Reactive Protein and Coronary Artery Calcium on Benefit Observed With Atorvastatin.
    J Am Coll Cardiol. 2018;71:2487-2488.
    PubMed     Text format    


    J Clin Endocrinol Metab

  62. PARK J, Blackburn BE, Ganz PA, Rowe K, et al
    Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005948. doi: 10.1210/jc.2017-02629.
    PubMed     Text format     Abstract available

  63. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Text format     Abstract available


    J Clin Invest

  64. THOSAR SS, Butler MP, Shea SA
    Role of the circadian system in cardiovascular disease.
    J Clin Invest. 2018;128:2157-2167.
    PubMed     Text format     Abstract available


    J Mol Cell Cardiol

  65. ZHANG J, Levy D, Oydanich M, Bravo C, et al
    A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion.
    J Mol Cell Cardiol. 2018 May 22. pii: S0022-2828(18)30175.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  66. DAVID TE
    Genes, aortic diseases, and cardiovascular surgery.
    J Thorac Cardiovasc Surg. 2018 May 5. pii: S0022-5223(18)31248.
    PubMed     Text format    

  67. VICECONTE M, Rocco IS, Pauletti HO, Vidotto M, et al
    Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass.
    J Thorac Cardiovasc Surg. 2018 May 1. pii: S0022-5223(18)31231.
    PubMed     Text format     Abstract available


    JAMA

  68. BHATT DL
    Percutaneous Coronary Intervention in 2018.
    JAMA. 2018;319:2127-2128.
    PubMed     Text format    


    N Engl J Med

  69. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed     Text format    


    PLoS One

  70. LENG RI
    A network analysis of the propagation of evidence regarding the effectiveness of fat-controlled diets in the secondary prevention of coronary heart disease (CHD): Selective citation in reviews.
    PLoS One. 2018;13:e0197716.
    PubMed     Text format     Abstract available


    Prog Cardiovasc Dis

  71. KAHLEOVA H, Levin S, Barnard ND
    Vegetarian Dietary Patterns and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30087.
    PubMed     Text format     Abstract available

  72. BITOK E, Sabate J
    Nuts and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30092.
    PubMed     Text format     Abstract available

  73. CHIAVAROLI L, Nishi SK, Khan TA, Braunstein CR, et al
    Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Prog Cardiovasc Dis. 2018 May 25. pii: S0033-0620(18)30094.
    PubMed     Text format     Abstract available


    Thromb Haemost

  74. CAPODANNO D, Greco A
    Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple.
    Thromb Haemost. 2018;118:949-952.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: